ArticlePDF Available

Development of a Rapid Method for the Screening of Conjugated Linoleic Acid (CLA)-Producing Strains of Bifidobacterium breve

Authors:

Abstract and Figures

This study was performed to isolate some strains of Bifidobacteriumbreve from fecal materials of neonates and to screen them for the biotransformation activity of converting linoleic acid into conjugated linoleic acid (CLA). Fecal samples were collected from twenty healthy neonates between 14 and 100 days old, and four hundred colonies were randomly selected from a Bifidobacterium selective transoligosaccharide medium. A duplex polymerase chain reaction technique was developed for the rapid and accurate molecular characterization of the B. breve strains that have been reported to show the species-specific characteristic of CLA production. They are identified by 16S ribosomal DNA, fructose-6-phosphate phosphoketolase encoding genes (xfp), and rapid pulsed field gel electrophoresis. Thirty-six isolates were identified as B. breve, and just two of the 12 neonates were harboring B. breve strains. Each isolate showed different CLA-producing ability in the spectrophotometric assay. All of the positive strains from the primary spectrophotometric assay were confirmed for their CLA-producing activities using gas-chromatographic analysis, and their conversion rates were different, depending on the strain isolated in this study. Some strains of B. breve were successfully isolated and characterized based on the CLA-producing activity, and further studies are necessary to characterize the enzyme and the gene responsible for the enzyme activity.
Content may be subject to copyright.
Korean Journal for Food Science of Animal Resources
Korean J. Food Sci. An. 2018 August 38(4):806~815 pISSN : 1225-8563 eISSN : 2234-246X
DOI https://doi.org/10.5851/kosfa.2018.e34 www.kosfa.or.kr
© Korean Society for Food Science of Animal Resources. This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License
(http://creativecommons.org/licences/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and r eproduction in any medium, provided the original work is properly cited.
Received July 30, 2018
Revised August 7, 2018
Accepted August 8, 2018
*Corresponding author : Geun-Bae Kim
Department of Animal Science and
Technology, Chung-Ang University,
Anseong 17546, Korea
Tel: +82-31-670-3027
Fax: +82-31-676-5986
E-mail: kimgeun@cau.ac.kr
These authors contributed equally to this
work.
Development of a Rapid Method for the Screening of
Conjugated Linoleic Acid (CLA)-Producing Strains
of Bifidobacterium breve
Sun-Hae Choi, Kyoung-Min Lee, Kwan-Hu Kim, and Geun-Bae Kim*
Department of Animal Science and Technology, Chung-Ang University, Anseong
17546, Korea
Abstract This study was performed to isolate some strains of Bifidobacterium breve
from fecal materials of neonates and to screen them for the biotransformation activity of
converting linoleic acid into conjugated linoleic acid (CLA). Fecal samples were
collected from twenty healthy neonates between 14 and 100 days old, and four hundred
colonies were randomly selected from a Bifidobacterium selective transoligosaccharide
medium. A duplex polymerase chain reaction technique was developed for the rapid and
accurate molecular characterization of the B. breve strains that have been reported to
show the species-specific characteristic of CLA production. They are identified by 16S
ribosomal DNA, fructose-6-phosphate phosphoketolase encoding genes (xfp), and rapid
pulsed field gel electrophoresis. Thirty-six isolates were identified as B. breve, and just
two of the 12 neonates were harboring B. breve strains. Each isolate showed different
CLA-producing ability in the spectrophotometric assay. All of the positive strains from
the primary spectrophotometric assay were confirmed for their CLA-producing activities
using gas-chromatographic analysis, and their conversion rates were different, depending
on the strain isolated in this study. Some strains of B. breve were successfully isolated
and characterized based on the CLA-producing activity, and further studies are necessary
to characterize the enzyme and the gene responsible for the enzyme activity.
Keywords probiotics, Bifidobacterium breve, duplex PCR, conjugated linoleic acid, rapid
screening
Introduction
The intestinal flora of an individual is composed of 100 trillion viable bacteria,
representing 100 or more different bacterial species. These organisms live together in
symbiotic or antagonistic relationships, growing on the food components ingested and
biocomponents secreted into the alimentary tract by the host (Mitsuoka, 2000).
Bifidobacteria are normal components of the intestinal flora throughout the life cycle.
They are ubiquitous, endosymbiotic inhabitants of the gastrointestinal tract, vagina, and
mouth. Bifidobacteria are the dominant species with Eubacterium, Clostridium, and
ARTICLE
Rapid Screening of CLA-producing Bifidobacterium breve Strains
807
Bacteroides in the colon flora, existing from 108 to 1011 per 1 g of colon contents (Mitsuoka, 1978).
Members of the genus Bifidobacterium are believed to exert various positive health benefits on their host. These beneficial
effects include anticarcinogenic activity (Biffi et al., 1997; Rafter et al., 2007; Reddy and Rivenson, 1993; Rowland et al.,
1998), modulation of immune response (Yasui and Ohwaki, 1991), improvement of the digestive system (Saavedra et al.,
1994), and lowering incidences of necrotizing enterocolitis in preterm neonates (Patole et al., 2016). According to a recent
report, there are some Bifidobacterium strains that can convert linoleic acid into bioactive conjugated linoleic acids (CLAs)
(Coakley et al., 2003; O’Shea et al., 2012).
The term “CLA” refers to a group of positional and geometric isomers of essential fatty-acid linoleic acid (LA, cis9, cis12-
C18:2) with conjugated double bonds, among which, the cis-9-,trans-11-ontadecadienoic acid (c9, t11 isomer) is approximately
80% of all possible CLA isomers (Pariza et al., 2001).
The conversion of linoleic acid to CLA takes place naturally in the rumen as part of the biohydrogenation process by the
action of rumen bacteria such as Butyrivibrio fibrisolvens (Griinari and Bauman, 1999). Therefore, CLA is present as a
natural component of ruminant meat as well as dairy products. There is increasing evidence of the potential health-promoting
properties of CLA isomers, including antiatherosclerosis (Lee et al., 1994), anticarcinogenesis (Tian et al., 2011),
enhancement of immunological function (Hayek et al., 1999), and reduction of body fat (Chaplin et al., 2015; Park et al.,
1997; West et al., 1998).
Many probiotic bacteria, especially some bifidobacteria, have been reported to exhibit bioconversion activity from LA
(linoleic acid) into CLA; however, this activity could be a strain-specific characteristic. From the screening of CLA
production with the major species of bifidobacteria, it has been demonstrated that the most-efficient CLA producers belong to
the species of B. breve (Barrett et al., 2007; Gorissen et al., 2010; Raimondi et al., 2016). In this study, a species-specific
duplex polymerase chain reaction (PCR) technique for the selection of many strains belonging to the species of B. breve was
developed, and this technique was successfully combined with a spectrophotometric assay for the rapid screening of probiotic
candidates harboring CLA-producing activity.
Materials and Methods
Bifidobacterium isolation from fecal materials of neonates
First, traditional colonies from neonatal feces were propagated under anaerobic conditions in transoligosaccharide (TOS)
agar (Yakult Honsha, Japan) at 37℃ for 48 h (Thitaram et al., 2005).
Bifidobacterium isolates were activated by successive subculturing into a Man-Rogosa-Sharpe (MRS) (Difco, USA) broth
supplemented with 0.05% L-cysteine·HCl and stored in 10% skim milk supplemented with glycerol in a –80℃ deep freezer.
As control strains, B. breve BB5 (Korea Yakult R & D Center) and B. breve LMC520 (Choi et al., 2008) were used for the
CLA production activity.
Identification of the isolates
Duplex PCR
Colonies grown on TOS agar were selected, and their genomic DNA was extracted with Lyse-N-Go (Pierce, USA) reagent
according to the manufacturer’s protocol. The primers used in the duplex PCR were a genus-specific primer based on xfp genes,
which encode fructose-6-phosphate phosphoketolase, and species-specific primers based on 16S rDNA from B. breve (Table 1).
Korean Journal for Food Science of Animal Resources Vol. 38, No. 4, 2018
808
16S rDNA partial sequencing
Colonies grown on TOS agar were selected, and the genomic DNA was extracted with Lyse-N-Go reagent, as
recommended. Then, DNA was added in a mixture of 25 µL HotSTARTaq Master mix (Qiagen, USA), and a 1 µL forward
and reverse primer set (GP116 & GP120) was used. The PCR product was purified using a PCR purification kit (Qiagen,
USA) and identified by a Basic Local Alignment Search Tool (BLAST) search.
F6PPK encoding gene sequencing
Primers used in the duplex PCR were genus-specific primers (GP109 & GP111) based on the xfp gene. The PCR product
was ligated into the pGEM-T easy vector (Promega, USA). The ligation product was transformed E. coli JM109 (Takara,
Japan) and grown in Luria-Bertani (LB) agar supplemented with 50 µg/mL of ampicillin and X-gal (LAX agar) plate at 37℃
overnight. White colonies selected were inoculated in LB broth supplemented with 50 µg/mL of ampicillin and grown under
150 rpm at 37℃ for 8 h. Plasmids from recombinant colonies were prepared by a miniprep kit (Qiagen, USA) and sequenced
with a SP6 and T7 primer pair (Macrogen, Korea). The sequence was identified by BLAST search.
Rapid pulsed field gel electrophoresis (PFGE)
According to the method of Briczinski and Roberts (2006), 2 mL of the overnight cultured cell was centrifuged at 14,000
rpm for 10 min and resuspended with 600 µL of 100 mM Tris EDTA buffer (pH 7.6). 160 µL of sample was added to 40 µL
of lysozyme (100 mg/mL) and 10 µL of proteinase K (20 mg/mL) and mixed with an equal volume of 1.6% InCert agarose
(Bio-Rad Laboratories, USA) prepared in 0.1% SDS (International Biotechnologies, USA). Blended samples were dispended
into disposable plug molds. The plugs were incubated in 0.5 M EDTA, 1% sarkosyl buffer (pH 9.0) supplemented by 2 mL of
lysozyme (4 mg/mL) and mutanolysin (200 unit/mL) at 55℃ for 90 min. After lysis, samples were cultured in fresh sarkosyl
buffer supplemented with proteinase K (0.5 mg/mL) at 55℃ for 1 h and washed in preheated distilled water at 50℃ for 15
min. The plugs were washed three times with 10 mM EDTA buffer (pH 7.6) at 50℃ for 15 min under 75 rpm in a shaking
water bath. After lysis, the plugs were sliced at comb size and then transferred to 200 µL of a fresh restriction digest mixture
containing 50 units of Xba I and incubated at 37℃ for 2 h.
Electrophoresis was performed on 1% InCert agarose gel using a 0.5× TBE buffer (Bio-Rad Laboratories, USA). A lambda
Table 1. Primers used in this study
Primers Description Sequence (5’ to 3’) Product
size (bp) References
GP-107 Forward; 16S rDNA for B. breve CCGGATGCTCCATCACAC 250 Matsuki et al. (2002)
GP-108 Reverse; 16S rDNA for B. breve ACAAAGTGCCTTGCTCCCT Matsuki et al. (2002)
GP-109 Forward 1; xfp for Bifidobacterium TGGCAGTCCAACAAGCTC 923 This study
GP-111 Reverse ; xfp for Bifidobacterium TAGGAGCTCCAGATGCCGTG This study
GP-110 Forward 2; xfp for Bifidobacterium CATCGACGGCAAGAAGACCG 582 This study
GP-111 Reverse ; xfp for Bifidobacterium TAGGAGCTCCAGATGCCGTG This study
GP-116 Forward; 27F, universal for bacteria AGAGTTTGATCCTGGCTCAG 1,450
GP-120 Reverse; 1492R, universal for bacteria GGTTACCTTGTTACGACTT
GP-145 Forward; BSH gene for B. breve ATGTGCACTGGTGTCCGTTTC 954 This study
GP-146 Reverse; BSH gene for B. breve TCATCGGGCGACGCTGCTG This study
Rapid Screening of CLA-producing Bifidobacterium breve Strains
809
ladder (Bio-Rad Laboratories, USA) was included as a molecular size marker. An electrophoresis machine was operated
using a CHEF DR-Ⅲ (Bio-Rad Laboratories, USA). Operation times were increased linearly at 6 V/cm and 14℃. After
electrophoresis, the gel was stained with ethidium bromide (0.4 mg/L; Promega, USA) for 1 h and then destained for 2 h with
distilled water. The band pattern was confirmed using a UV transilluminator.
Screening of CLA-producing lactic-acid bacteria
Spectrophotometric assay
According to the method of Barrett et al. (2007), strains were incubated anaerobically in an mMRS broth containing
linoleic acid (0.5 mg/mL) and 2% (wt/vol) Tween 80 at 37℃ for 24 h. Following incubation, 1 mL of culture was centrifuged
at 20,800×g for 1 min, the pellet was discarded, and the supernatant (0.5 mL) was mixed with 0.5 mL of hexane by vortexing
for 2 min. 0.2 mL of the fatty acids extracted by vortexing the solution was mixed with 0.8 mL of methanol. The presence of
CLA in the culture supernatant was assayed using a spectrophotometer (smart plus SP-1900PC, Youngwoo, Korea) at 233 nm.
Gas chromatography (GC)
According to the method of Jung et al. (2006), strains were incubated anaerobically in a mMRS broth containing linoleic
acid (0.5 mg/mL) and 2% (wt/vol) Tween 80 at 37℃ for 24 h. 0.5 mL of the sample was mixed with 20 μL of stock (8 mL of
hexane, 100 mg of internal standard, C17:0) and 0.5 mL of hexane. After tilting for 10 min, the hexane layer was extracted by
centrifuge. The hexane layer was dried under nitrogen gas at 60℃ for 30 min.
Fatty acid was methylated in 1% HCl at 60℃ for 30 min. Fatty-acid methyl esters were produced by adding 2 mL of
saturated NaCl and 1 mL of hexane. The solvent was dried under nitrogen gas and concentrated with 100 µL of hexane.
Methylated fatty acids were analyzed with a gas chromatographer (Varian STAR 3400, USA) equipped with an SP-2560
column and a flame ionization detector.
Results and Discussion
Selection of bifidobacteria
Twelve neonatal feces were plated on TOS agar and incubated under anaerobic conditions at 37℃ for 48 h. Four hundred
typical milky-white colonies were selected from agar plate and were subcultured in MRS broth. Isolated strains were stored in
10% skim-milk-supplemented glycerol in a –80℃ deep freezer.
Identification of the genus Bifidobacterium
Duplex PCR
Conventional biochemical tests have some limitations in identifying specific species and discriminating a large number of
isolates. Thus, in this study, duplex PCR that can simultaneously accomplish the rapid identification and the correct
differentiation of B. breve was developed.
The PCR assay was conducted with genus-specific primers (Table 1; GP109 & GP111 and GP111 & GP110) for the genus
Bifidobacterium, producing products of 923 bp and 582 bp, respectively. As a result of PCR with species-specific primers
(GP107 & GP108), it was confirmed that 250 bp PCR product was obtained from only B. breve strains (Fig. 1).
Korean Journal for Food Science of Animal Resources Vol. 38, No. 4, 2018
810
To increase the specificity of the PCR, a duplex PCR was conducted with multiplex primer sets, and two pairs of genus-
specific primer (GP109 & GP111, GP145 & GP146) and a pair of species-specific primer (GP107 & GP108) were used. After
the evaluation process, primer pairs (GP109 & GP111 and GP107 & GP108) producing products of 923 bp and 250 bp were
selected because this set was better than the other sets producing products of 582 bp and 250 bp in terms of the band
separation (Fig. 1A).
Through the duplex PCR assay developed in this study, we were able to confirm 36 strains B. breve from total 400 strains
of Bifidobacterium isolated from new born infants. Some of the typical PCR band pattern for B. breve strains, which produce
the PCR products of 923 bp and 250 bp are presented in Fig. 1B.
It is generally accepted that the predominant microorganisms in the colon of breast-fed babies are bifidobacteria, while the
colons of bottle-fed babies contain various other bacteria. Mitsou et al. (2007) reported that Bifidobacterium longum and
Bifidobacterium breve were the most frequently detected Bifidobacterium species in breast-fed infants.
In this study, B. breve was isolated from two infants among 12 infants. Only one strain among 40 strains from one person was
identified as a B. breve, but 31 strains among 40 strains from another person were identified as B. breve, proving significant
differences depending on the host.
16S rDNA partial sequencing
As a result of sequencing the 16S rDNA of B. breve by duplex PCR, all strains had high homology with B. breve,
indicating that all strains were B. breve. If the sequence of the 16S rRNA gene has more than 97% species sequence identity,
they are considered to be the same species (Stackebarandt and Goebel, 1994). Bifidobacterium breve ATCC 15700T and
commercial strain BB5 have 98% sequence identity, and B. breve ATCC 15700T and IB84 strain have 99% sequence identity.
As a result of comparing the nucleotide sequence by clustal W to confirm the difference between the strains of isolated B.
breve, all strains have the same 16S rDNA except BB5. Although it is difficult to identify the strain because of the high
homology of the DNA sequence between genus Bifidobacterium, studies, such as those on multiple PCR (Kwon et al., 2005;
Ventura et al., 2004) and DGGE (Satokari et al., 2001), have been conducted to identify Bifidobacterium, and it was found to
be a convenient and accurate method for the identification of strain level.
Fig. 1. Agarose gel electrophoresis of PCR products. (A) establishment of duplex PCR condition M: 1 kb ladder; lane 1: Bifidobacterium-
specific PCR product (923 kb) & B. breve-specific PCR product (250 bp); lane 2: Bifidobacterium-specific PCR product (582 bp) & B. breve-
specific PCR product (250 bp); lane 3: B. breve-specific PCR product (250 bp); lane 4: Bifidobacterium-specific PCR product (923 kb); lane 5
Bifidobacterium-specific PCR product (582 kb). (B) Identification of Bifidobactetrium breve. M: 1 kb ladder; lane 1–10: Bifidobacterium
strains isolated from infant feces. Dual bands of PCR products (lanes 1, 2, 4, 6, 7, 8, 9) represent B. breve strains and the others (lanes 3, 5,
and 10) are belonging to the other species of Bifidobacterium. PCR, polymerase chain reaction.
Rapid Screening of CLA-producing Bifidobacterium breve Strains
811
F6PPK encoding gene sequencing
PCRs were conducted with genus-specific primers, and the PCR products were cloned into a pGEM-T easy vector. As a
result of comparing the sequence by clustal W, the IB sample corresponded with B. breve ATCC 15700T, and the BB5 sample
and B. breve ATCC 15700T showed difference in six nucleotides.
Rosselló-Mora and Amman (2001) reported that the 16S rRNA gene sequence cannot distinguish clearly between
difference species belonging to the same genus of bacteria. Berthoud et al. (2005) identified Bifidobacterium by the xfp gene
and reported that the xfp gene sequencing is more accurate than the 16S rRNA gene sequencing, except for B. thermophilum,
B. thermacidophilum, and B. boum. In this study, it was also confirmed that in addition to 16S rRNA gene sequencing, xfp
gene sequencing could be used as a tool of identification for the isolated B. breve strains (data not shown).
Rapid PFGE
For the genotyping and genetic fingerprinting of the bacterial isolates, PFGE was applied using Xba I as restriction
enzymes. As shown in Fig. 2, PFGE analysis indicated that there was high correlation between new isolated strains (lane 2 to
lane 6) and different band pattern was observed from KCTC strains (land 8 to lane 11). Briczinski and Roberts (2006)
reported that there is no difference between a PFGE protocol consuming 5–7 days and a rapid protocol that takes 24 h. In this
study, PFGE was carried out using a rapid protocol, and it was confirmed that the band of the sample isolated from the same
infants also showed the same patterns (Fig. 2).
Screening of CLA producing lactic-acid bacteria
Spectrophotometric assay
The standard gas liquid chromatography-based screening process is laborious and time-consuming and can be a limiting
factor when a large number of strains are being tested. In this study, a simple and straightforward spectrophotometric method
was used for screening a large number of culture supernatants for the CLA production. Through the spectrophotometric assay,
the present study confirmed that B. breve isolated from neonatal feces produces CLA, but three species of B. breve received
Fig. 2. PFGE pattern of genomic DNA of Bifidobacterium strains after digestion by Xba I. Lane M, lambda ladder; lane 1, BB5; lane 2, IB26
lane 3, IB51; lane 4, IB55; lane 5, IB 62; lane 6, LMC520; lane 7, B. breve 2003; lane 8, B. breve KCTC 3220; lane 9, B. breve KCTC 3419; lane
10, B. breve KCTC 5081; lane 11, B. breve KCTC 3441; lane 12, B. longum BBL. PFGE, rapid pulsed field gel electrophoresis.
Korean Journal for Food Science of Animal Resources Vol. 38, No. 4, 2018
812
from Korean Collection of Type Cultures (B. breve KCTC 3220, B. breve KCTC 3419, B. breve KCTC 5018) and B. breve
2003 do not produce CLA (Fig. 3).
As a result of the spectrophotometric assay, CLA-producing ability was different depending on the strains tested, and it was
observed that some of those isolates had higher CLA production activity than that of LMC520, which is one of the best CLA-
producing strains (Choi et al., 2008).
Pariza and Yang (1999) reported that CLA detection is possible through the spectrophotometric assay, and Barrett et al.
(2007) isolated and identified CLA-producing strains. In this study, the prescreening process was successful through the
spectrophotometric assay, and the fatty acid analysis was carried out by GC for a more accurate quantitative analysis (Fig. 3).
Gas chromatography (GC)
Strains that had a high optical density value in the spectrophotometer assay were analyzed by GC to find excellent strains
for the CLA production. First, the peak pattern of fatty-acid methyl ester (FAME) was analyzed using linoleic acid and
conjugated methyl ester (Sigma, USA).
It was observed that linoleic acid was converted to CLA by B. breve isolated from neonatal feces through chromatograms
(Fig. 4) with c9, t11-form as a major form of isomers of conjugated CLA. As shown in Fig. 5, conversion rates from LA into
CLA was different depending on the strains. Among the isolated B. breve strains, IB52 and IB84 strains showed more than 65%
conversion rate, which is comparable with LMC 520 strain (Choi et al., 2008). Many studies reported that free linoleic acid
inhibits the growth of CLA-producing strains (Jiang et al., 1998; Kim et al., 2000; Rainio et al., 2001), and Tween 80
neutralizes the antibacterial activity and increases the solubility of the fatty acid in the liquid medium (Jiang et al., 1998;
Rainio et al., 2001).
The study of the effect of the content of Tween 80 confirmed that the conversion rate of the medium containing 5% Tween
80 was higher than that of 2% Tween 80 (data not shown). The conversion rates of the isolates IB52, IB84, and LMC 520
were almost the same as that of LMC 520, and the conversion rate of IB84 was slightly higher than that of LMC 520.
Coakley et al. (2003) reported that B. breve and B. dentium have the highest productivity, comparing the conversation rate of
CLA by Bifidobacterium isolated from neonatal feces, and Oh et al. (2003) confirmed that B. breve and B. pseudocatenulatum
Fig. 3. Screening of B. breve isolates for the production of CLA using spectrophotometric assay. Negative control: B. longum ATCC
15700T; Positive control: LMC520; Commercial strain: BB5; Isolated strains from infant feces: IB7, IB13, IB29, IB30, IB31, IB32, IB52, IB54,
IB55, IB75, IB80, IB84. CLA, conjugated linoleic acid.
Rapid Screening of CLA-producing Bifidobacterium breve Strains
813
produce CLA. In this study, only B. breve had CLA-producing ability among 400 Bifidobacterium strains from neonatal feces.
Conclusion
Among the 400 strains identified out of 12 fecal isolates, 36 strains of B. breve were selected through duplex PCR. The
screening study showed that IB52, IB80, and IB84 had CLA-producing ability converted from linoleic acid. In this study,
using a duplex PCR for the selection of B. breve strains was a useful and precise method of selecting CLA-producing strains
from human feces. Selected strains are expected to be widely used in materials of fermented milk products and health food.
There are many studies that reported the efficacy of CLA-producing strains, including B. breve, through clinical trials. Further
studies are necessary to clarify CLA-producing ability from linoleic acid by B. breve in the body.
Acknowledgement
This research was supported by the Chung-Ang University Research Scholarship Grants in 2012.
Fig. 4. Chromatogram of conjugated linoleic acid (CLA) analysis with gas chromatograph. Heptadecanoic acid (C17:0) was used as an internal
standard. After 24 hr incubation, most of linoleic acid was converted into c9, t11-CLA and minor portion of t10, c12-CLA was also detected.
Fig. 5. Conversion rates of conjugated linoleic acids (cis-9, trans-11 isomer) from 24 h growth culture of Bifidobacterium breve strains in
MRS broth. The linoleic acid was added as a 50 mg/mL stock soluon containing 2% (v⁄v) Tween 80 and was previously filter sterilized
through a 0.45 μm filter. MRS, Man-Rogosa-Sharpe.
Korean Journal for Food Science of Animal Resources Vol. 38, No. 4, 2018
814
References
Barrett E, Ross RP, Fitzgerald GF, Stanton C. 2007. Rapid screening method for analyzing the conjugated linoleic acid
production capabilities of bacterial cultures. Appl Environ Microbiol 73:2333-2337.
Berthoud H, Chavagnat F, Haueter M, Casey MG. 2005. Comparison of partial gene sequences encoding a phosphoketolase
for the identification of bifidobacteria. LWT-Food Sci Technol 38:101-105.
Biffi A, Coradini D, Larsen R, Riva L, Fronzo GD. 1997. Antipoliferative effect of fermented milk on the growth of a human
cancer cell line. Nutr Cancer 28:93-99.
Briczinski EP, Roberts RF. 2006. A rapid pulsed-field gel electrophoresis method for analysis of bifidobacteria. J Dairy Sci
89:2424-2427.
Chaplin A, Parra P, Serra F, Palou A. 2015. Conjugated linoleic acid supplementation under a high-fat diet modulates stomach
protein expression and intestinal microbiota in adult mice. PLoS ONE 10:e0125091.
Choi NJ, Park HG, Kim YJ, Kim IH, Kang HS, Yoon CS, Yoon HG, Park SI, Lee JW, Chung SH. 2008. Utilization of
monolinolein as a substrate for conjugated linoleic acid production by Bifidobacterium breve LMC 520 of human
neonatal origin. J Agric Food Chem 56:10908-10912.
Coakley M, Ross RP, Nordgren M, Fitzgerald G, Devery D, Stanton C. 2003. Conjugated linoleic acid biosynthesis by
human-derived Bifidobacterium species. J Appl Microbiol 94:138-145.
Gorissen L, Raes K, Weckx S, Dannenberger D, Leroy F, De Vuyst L, De Smet S. 2010. Production of conjugated linoleic
acid and conjugated linolenic acid isomers by Bifidobacteirum species. Appl Microbial Biotechnol 87:2257-2266.
Griinari JM, Bauman DE. 1999. Biosynthesis of conjugated linoleic acid and its incorporation into meat and milk in
ruminants. In Advances in conjugated linoleic acid research. Yurawez MP, Mossoba MM, Kramer JKG, Pariza MW,
Nelson GJ (ed). AOCS Press, Champaign, IL. pp 180-200.
Hayek MG, Han SN, Wu D, Watkins BA, Meydani M, Dorsey JL, Smith DE, Meydani SN. 1999. Dietary conjugated linoleic
acid influences the immune response of young and old C57BL ∕ 6NCrlBR mice. J Nutr 129:32-38.
Jiang J, Björck L, Fonden R. 1998. Production of conjugated linoleic acid by dairy starter cultures. J App Microbiol 81:95-102.
Jung MY, Kim GB, Jang ES, Jung YK, Park SY, Lee BH. 2006. Improved extraction method with hexane for gas
chromatographic analysis of conjugated linoleic acids. J Dairy Sci 89:90-94.
Kim YJ, Liu RH, Bond DR, Russel JB. 2000. Effect of linoleic acid concentration on conjugated linoleic acid production by
Butyrivibrio fibrisolvens A38. Appl Environ Microbiol 66:5226-5230.
Kwon HS, Yang EH, Lee SH, Yeon SW, Kang BH, Kim TY. 2005. Rapid identification of potentially probiotic
Bifidobacterium species by multiplex PCR using species-specific primers based on the region extending from 16S rRNA
through 23S rRNA. FEMS Microbiol Lett 250:55-62.
Lee KN, Kritchevsky D, Parizaa MW. 1994. Conjugated linoleic acid and artherosclerosis in rabbits. Atherosclerosis 108:19-25.
Matsuki T, Watanabe K, Tanaka R. 2002. Genus- and species-specific PCR primers for the detection and identification of
bifidobacteria. Curr Issues Intest Microbiol 4:61-69.
Mitsuoka T. 1978. Intestinal bacteria and health: An introductory narrative. Iwanami Shoten Publishers, Tokyo, Japan.
Mitsuoka T. 2000. Significance of dietary modulation of intestine flora and intestinal environment. Biosci Microflora 19:15-25.
Oh D, Hong G, Lee Y, Min S, Sin H, Kim S. 2003. Production of conjugated linoleic acid by isolated Bifidobacterium strains.
J Microbiol Biotechnol 19:907-912.
Rapid Screening of CLA-producing Bifidobacterium breve Strains
815
O’Shea EF, Cotter PD, Stanton C, Ross RP, Hill C. 2012. Production of bioactive substances by intestinal bacteria as a basis
of explaining probiotic mechanisms: Bacteriocins and conjugated linoleic acid. Int J Food Microbiol 152:189-205.
Pariza MW, Yang XY. 1999. Method of producing conjugated fatty acids. US Patent 5,856,149.
Park Y, Albright KJ, Liu W, Storkson JM, Cook ME, Pariza MW. 1997. Effect of conjugated linoleic acid on body
composition in mice. Lipids 32:853-858.
Pariza MW, Park Y, Cook ME. 2001. The biologically active isomers of conjugated linoleic acid. Prog Lipid Res 40:283-298.
Patole SK, Rao SC, Keil AD, Nathan EA, Doherty DA, Slimmer KN. 2016. Benefits of Bifidobacterium breve M-16V
supplementation in preterm neonates - A retrospective cohort study. PLoS ONE 11:e0150775.
Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, Klinder A, O'Riordan M, O'Sullivan GC, Pool-Zobel B,
Rechkemmer G, Roller M, Rowland I, Salvadori M, Thijs H, Loo JV, Watzl B, Collins JK. 2007. Dietary synbiotics
reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr 85:488-496.
Raimondi S, Amaretti A, Leonardi A, Quartieri A, Gozzoli C, Rossi M. 2016. Conjugated linoleic acid production by
bifidobacteria: Screening, kinetic, and composition. Biomed Res Int 2016:8654317.
Rainio A, Vahvaselkä M, Suomalainen T, Laakso S. 2001. Reduction of linoleic acid inhibition in production of conjugated
linoleic acid by Propionibacterium freudenreichii spp. shermanii. Can J Microbiol 47:735-740.
Reddy BS, Rivenson A. 1993. Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis
induced by 2-amino-3-methylimidazo [4,5f] quinoline, a food mutagen. Cancer Res 53:3914-3918.
Rosselló-Mora R, Amman R. 2001. The species concept for prokaryotes. FEMS Microbiol Rev 25:39-67.
Rowland IR, Rumney CJ, Coutts JT, Lievense LC. 1998. Effect of Bifidobacterium longum and inulin on gut bacterial
metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 19:281-285.
Saavedra JM, Bauman NA, Perma JA, Yolken RH, Saavedra JM, Bauman NA, Oung I. 1994. Feeding of Bifidobacterium
bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet
344:1046-1049.
Satokari RM, Vaughan EE, Akkermans ADL, Saarela M, De Vos WM. 2001. Bifidobacterial diversity in human feces
detected by genus-specific PCR and denaturing gradient gel electrophoresis. Appl Environ Microbiol 67:504-513.
Stackebrandt E, Goebel BM. 1994. A place for DNA-DNA reassociation and 16S rRNA sequence analysis in the present
species definition in bacteriology. Int J Syst Bacteriol 44:846-849.
Thitaram SN, Siragusa GR, Hinton A Jr. 2005. Bifidobacterium-selective isolation and enumeration from chicken caeca by a
modified oligosaccharide antibiotic-selective agar medium. Lett Appl Microbiol 41:355-360.
Tian M, Kliewer KL, Asp ML, Stout MB, Belury MA. 2011. c9,t11-Conjugated linoleic acid-rich oil fails to attenuate
wasting in colon-26 tumor-induced late-stage cancer cachexia in male CD2F1 mice. Mol Nutr Food Res 55:268-277.
Ventura M, van Sinderen D, Fitzgerald GF, Zink R. 2004. Insights into the taxonomy, genetics and physiology of
bifidobacteria. Antonie van Leeuwenhoek 86:205-223.
West DB, Delany JP, Camet PM, Bolhm F, Truett AA, Scimeca JA. 1998. Effects of conjugated linoleic acid on body fat and
energy metabolism in the mouse. Am J Physiol 275:667-672.
Yasui H, Ohwaki M. 1991. Enhancement of immune response in Peyer’s patch cells cultured with Bifidobacterium breve. J
Dairy Sci 74:1187-1195.
... 68 LMC 052 (57.20%), 69 and IB52 (>65%). 71 Physicochemical analyses revealed that the 37 kDa LAI is generally hydrophobic and stable, which is typical for membrane-associated proteins. 72 Additionally, the GRAVY score of LAI was above zero, indicating that it was membranous and hydrophobic in nature. ...
Article
The probiotic Bifidobacterium breve is known for its efficient conjugated linoleic acid (CLA) conversion, yet their CLA conversion pathway remains underexplored. This study investigated B. breve JKL2022 for its CLA conversion in actively growing cells, washed cell states, and in crude protein extracts. Moreover, the study aimed to confirm the CLA-converting enzyme in strain JKL2022 and optimize its purification through heterologous expression of fusion proteins (LAI_sGFP and MBP_LAI). JKL2022 exhibited superior CLA conversion compared to genetically similar B. breve strains (JCM7017, JCM7019, JCM1192, and JCM1273), particularly the observed CLA conversion in washed cells (60.14 ± 7.60%) and crude protein fractions (96.11 ± 6.63%). The multipass transmembrane linoleic acid isomerase (LAI) was cloned into the E. coli BL21(DE3) as free LAI or modified with superfolder-GFP or MBP tags and expressed with 0.01 mM IPTG at 37 °C, resulting in highly active protein fractions. LAI was characterized by predictive modeling, molecular docking, and phylogenetic analyses. Moreover, reverse transcription-quantitative PCR analysis revealed upregulation (20–140× higher expression) of lai in JKL2022 compared with that in the JCM strains. Nevertheless, upscaling the production and purification of LAI for downstream applications remains a challenge, primarily because of their membrane-spanning configuration.
Article
Conjugated linoleic acid (CLA), a group of 18 carbon conjugated dienoic acids, has been considered a promising food supplement owing to its various physiological benefits to human health. Owing to a high isomer selectivity of the product and a simple isolation and purification process, microbial CLA has become a research hotspot. Many food-grade bacteria such as Lactobacillus and Bifidobacterium have been reported to possess CLA-production ability. Particularly, Bifidobacterium has high bio-conversion rate and enhanced CLA production, and is one of the best and most promising CLA producers among microorganisms. Consequently, this article aimed to review the current knowledge about Bifidobacterium CLA producers, the complex factors regulating CLA production in Bifidobacterium, the role of CLA production in Bifidobacterium, and the potential mechanism underlying Bifidobacterium CLA production. In summary, the above information offers novel insights into the production of food-grade CLA as well as the rational design of health-promoting fermented foods or synbiotics.
Article
Full-text available
Conjugated linoleic acids (CLA) are positional and geometric isomers of linoleic acid involved in a number of health aspects. In humans, CLA production is performed by gut microbiota, including some species of potential probiotic bifidobacteria. 128 strains of 31 Bifidobacterium species were screened with a spectrophotometric assay to identify novel CLA producers. Most species were nonproducers, while producers belonged to B. breve and B. pseudocatenulatum . GC-MS revealed that CLA producer strains yielded 9 cis ,11 trans -CLA and 9 trans ,11 trans -CLA, without any production of other isomers. Hydroxylated forms of LA were absent in producer strains, suggesting that the myosin-cross-reactive antigen (MCRA) protein that exerts hydratase activity is not involved in LA isomerization. Moreover, both CLA producer and nonproducer species bear a MCRA homologue. The strain B. breve WC 0421 was the best CLA producer, converting LA into 68.8% 9 cis ,11 trans -CLA and 25.1% 9 trans ,11 trans -CLA. Production occurred mostly during the lag and the exponential phase. For the first time, production and incorporation of CLA in biomass were assessed. B. breve WC 0421 stored CLA in the form of free fatty acids, without changing the composition of the esterified fatty acids, which mainly occurred in the plasmatic membrane.
Article
Full-text available
Background: Systematic reviews of randomised controlled trials report that probiotics reduce the risk of necrotising enterocolitis (NEC) in preterm neonates. Aim: To determine whether routine probiotic supplementation (RPS) to preterm neonates would reduce the incidence of NEC. Methods: The incidence of NEC ≥ Stage II and all-cause mortality was compared for an equal period of 24 months 'before' (Epoch 1) and 'after' (Epoch 2) RPS with Bifidobacterium breve M-16V in neonates <34 weeks. Multivariate logistic regression analysis was conducted to adjust for relevant confounders. Results: A total of 1755 neonates (Epoch I vs. II: 835 vs. 920) with comparable gestation and birth weights were admitted. There was a significant reduction in NEC ≥ Stage II: 3% vs. 1%, adjusted odds ratio (aOR) = 0.43 (95%CI: 0.21-0.87); 'NEC ≥ Stage II or all-cause mortality': 9% vs. 5%, aOR = 0.53 (95%CI: 0.32-0.88); but not all-cause mortality alone: 7% vs. 4%, aOR = 0.58 (95% CI: 0.31-1.06) in Epoch II. The benefits in neonates <28 weeks did not reach statistical significance: NEC ≥ Stage II: 6% vs. 3%, aOR 0.51 (95%CI: 0.20-1.27), 'NEC ≥ Stage II or all-cause mortality', 21% vs. 14%, aOR = 0.59 (95%CI: 0.29-1.18); all-cause mortality: 17% vs. 11%, aOR = 0.63 (95%CI: 0.28-1.41). There was no probiotic sepsis. Conclusion: RPS with Bifidobacterium breve M-16V was associated with decreased NEC≥ Stage II and 'NEC≥ Stage II or all-cause mortality' in neonates <34 weeks. Large sample size is required to assess the potential benefits of RPS in neonates <28 weeks.
Article
Full-text available
The gastrointestinal tract constitutes a physiological interface integrating nutrient and microbiota-host metabolism. Conjugated linoleic acids (CLA) have been reported to contribute to decreased body weight and fat accretion. The modulation by dietary CLA of stomach proteins related to energy homeostasis or microbiota may be involved, although this has not been previously analysed. This is examined in the present study, which aims to underline the potential mechanisms of CLA which contribute to body weight regulation. Adult mice were fed either a normal fat (NF, 12% kJ content as fat) or a high-fat (HF, 43% kJ content as fat) diet. In the latter case, half of the animals received daily oral supplementation of CLA. Expression and content of stomach proteins and specific bacterial populations from caecum were analysed. CLA supplementation was associated with an increase in stomach protein expression, and exerted a prebiotic action on both Bacteroidetes/Prevotella and Akkermansia muciniphila. However, CLA supplementation was not able to override the negative effects of HF diet on Bifidobacterium spp., which was decreased in both HF and HF+CLA groups. Our data show that CLA are able to modulate stomach protein expression and exert a prebiotic effect on specific gut bacterial species.
Article
The human intestines harbor 100 trillion viable bacteria, reaching 100 kinds, which consist of so-called intestinal flora. These bacteria grow on the food components ingested and bio-components secreted into the alimentary tract as nutrients. The composition of the intestinal flora can be altered by many factors such as aging, physiological state, drugs, various diseases, diet, and stresses, and has an influence on intestinal metabolisms, which have a great influence on nutrition, drug efficacy, physiological function, aging, carcinogenesis, immunity, infection and others in the host. Thus, it was revealed that the intestinal flora have a close relationship to both the health and diseases of the host. Furthermore, it was found that it is important to increase beneficial bacteria such as bifidobacteria and to decrease harmful bacteria such as clostridia among the intestinal flora for prophylaxis against geriatic diseases including cancers. It is now well established that foods and food components contribute to physiologic and biologic well-being. Optimal intestinal flora and intestinal environment are possibly achieved by a nutritionally well-balanced diet and the active intake of functional foods such as oligosaccharides, dietary fiber and fermented milks, which promote useful bacteria or suppress harmful bacteria. Recent advances of research in intestinal flora are the background for the appearance of functional foods. The functional foods are classified into 3 groups based on their mechanisms of action: “probiotics, ” “prebiotics” and “biogenics.” Probiotics are viable microorganisms, such as lactobacilli and bifidobacteria, which beneficially affect the host by improving the intestinal bacterial balance. Prebiotics are non-digestible food ingredients, such as oligosaccharides and dietary fiber, which beneficially affect the host by selectively stimulating the growth or activities of beneficial intestinal bacteria in the colon, and thus improve the health of the host. Biogenics include biologically active peptides, including immunopotentiator (biological response modifier: BRM), plant flavonoids, etc. They act directly or indirectly, through the modulation of intestinal flora, on health of the host. Probiotics and prebiotics act on the intestinal flora and improve the balance of the flora by enhancing the growth of beneficial intestinal bacteria and/or inhibiting the growth of harmful ones, resulting in scavenging in the intestinal environment. They often induce the production of biogenics such as antibacterial substances, immunopotentiators, etc. by the proliferation of beneficial intestinal bacteria. Thus, the functional foods enhance bio-regulation such as stresses, appetite and absorption, bio-defence such as immunity and anti-allergy, prevent diseases including diarrhea, constipation, cancer, cholesterolemia and diabetes, and suppress aging through immunostimulation as well as the suppression of mutagenesis, carcinogenesis, oxidation processes, intestinal putrefaction and cholesterolemia.
Article
Because a natural entity 'species' cannot be recognized as a group of strains that is genetically well separated from its phylogenetic neighbors, a pragmatic approach was taken to define a species by a polyphasic approach (L. G. Wayne, D. J. Brenner, R. R. Colwell, P. A. D. Grimont, O. Kandler, M. I. Krichevsky, L. H. Moore, W. E. C. Moore, R. G. E. Murray, E. Stackebrandt, M. P. Starr, and H. G. Truper, Int. J. Syst. Bacteriol. 37:463-464, 1987), in which a DNA reassociation value of about 70% plays a dominant role. With the establishment of rapid sequence analysis of 16S rRNA and the recognition of its potential to determine the phylogenetic position of any prokaryotic organism, the role of 16S rRNA similarities in the present species definition in bacteriology needs to be clarified. Comparative studies clearly reveal the limitations of the sequence analysis of this conserved gene and gene product in the determination of relationships at the strain level for which DNA-DNA reassociation experiments still constitute the superior method. Since today the primary structure of 16S rRNA is easier to determine than hybridization between DNA strands, the strength of the sequence analysis is to recognize the level at which DNA pairing studies need to be performed, which certainly applies to similarities of 97% and higher.
Article
Two isolates from Korean faecal samples converted linoleic acid (LA) into conjugated linoleic acid (CLA), and were identified as Bifidobacterium breve and Bifidobacterium pseudocatenulatum by analysis of 16S rRNA sequences. In both cases, the major CLA was the cis-9, trans-11 isomer and CLA production paralleled the increase in cell biomass with both bacteria and was maximal at 30 h. The quantities of supernatant CLA produced by B. breve and B. pseudocatenulatum were 160 and 135 mg l–1, from 500 mg LA l–1, respectively. In the presence of 0.05% LA, the growth of B. breve was weakly inhibited but that of B. pseudocatenulatum was not affected over 6 days fermentation. During fermentation, the majority of CLA isomers were in the culture supernatant, but with washed cells obtained at the early stationary phase, 36 h, about 40% was detected in the cellular lipid. The optimal culture age with equal concentrations of washed cells for CLA production by the two bifidobacteria was determined to be 36 h. At this culture age, total CLA conversion of supernatant and cell pellets was 78% in B. breve and 69% in B. pseudocatenulatum from 0.01% LA.
Article
In this study, a new identification method for Bifidobacterium species based on sequencing of a partial xylulose-5-phosphate/fructose-6-phosphate phosphoketolase gene (xfp) was evaluated. Approximately 500 bp sequences from 68 different strains including 34 type strains were compared. The results showed that this method discriminated between all bifidobacteria, generally with greater accuracy than 16S rDNA sequence analysis. It even clearly distinguished B. longum biovar infantis from B. longum biovar longum and B. longum biovar suis, as well as B. animalis from B. lactis.
Article
The mechanisms by which intestinal bacteria achieve their associated health benefits can be complex and multifaceted. In this respect, the diverse microbial composition of the human gastrointestinal tract (GIT) provides an almost unlimited potential source of bioactive substances (pharmabiotics) which can directly or indirectly affect human health. Bacteriocins and fatty acids are just two examples of pharmabiotic substances which may contribute to probiotic functionality within the mammalian GIT. Bacteriocin production is believed to confer producing strains with a competitive advantage within complex microbial environments as a consequence of their associated antimicrobial activity. This has the potential to enable the establishment and prevalence of producing strains as well as directly inhibiting pathogens within the GIT. Consequently, these antimicrobial peptides and the associated intestinal producing strains may be exploited to beneficially influence microbial populations. Intestinal bacteria are also known to produce a diverse array of health-promoting fatty acids. Indeed, certain strains of intestinal bifidobacteria have been shown to produce conjugated linoleic acid (CLA), a fatty acid which has been associated with a variety of systemic health-promoting effects. Recently, the ability to modulate the fatty acid composition of the liver and adipose tissue of the host upon oral administration of CLA-producing bifidobacteria and lactobacilli was demonstrated in a murine model. Importantly, this implies a potential therapeutic role for probiotics in the treatment of certain metabolic and immunoinflammatory disorders. Such examples serve to highlight the potential contribution of pharmabiotic production to probiotic functionality in relation to human health maintenance.
Article
Despite the generally accepted importance of bifidobacteria as probiotic components of the human intestinal microflora and their use in health promoting foods, there is only limited information about their phylogenetic position, physiology and underlying genetics. In the last few years numerous molecular approaches have emerged for the identification and characterization of bifidobacterial strains. Their use, in conjunction with traditional culturing methods, has led to a polyphasic taxonomy which has significantly enhanced our knowledge of the role played by these bacteria in the human intestinal ecosystem. The recent adaptation of culture-independent molecular tools to the fingerprinting of intestinal and food communities offers an exciting opportunity for revealing a more detailed picture of the true complexity of these environments. Furthermore, the availability of bifidobacterial genome sequences has advanced knowledge on the genetics of bifidobacteria and the effects of their metabolic activities on the intestinal ecosystem. The release of a complete Bifidobacterium longum genome sequence and the recent initiative to sequence additional strains are expected to open up a new era of comparative genomics in bifidobacterial biology. Moreover, the use of genomotyping allows a global comparative analysis of gene content between different bifidobacterial isolates of a given species without the necessity of sequencing many strains. Genomotyping provides useful information about the degree of relatedness among various strains of Bifidobacterium species and consequently can be used in a polyphasic identification approach. This review will deal mainly with the molecular tools described for bifidobacterial identification and the first insights into the underlying genetics involved in bifidobacterial physiology as well as genome variability.
Article
Cancer cachexia is characterized by muscle and adipose tissue wasting caused partly by chronic, systemic inflammation. Conjugated linoleic acids (CLAs) are a group of fatty acids with various properties including anti-inflammatory cis9, trans11 (c9t11)-CLA and lipid-mobilizing trans10, cis12 (t10c12)-CLA. The purpose of this study was to test whether dietary supplementation of a c9t11-CLA-rich oil (6:1 c9t11:t10c12) could attenuate wasting of muscle and adipose tissue in colon-26 adenocarcinoma-induced cachexia in mice. Loss of body weight, muscle and adipose tissue mass caused by tumors were not rescued by supplementation with the c9t11-CLA-rich oil. In quadriceps muscle, c9t11-CLA-rich oil exacerbated tumor-induced gene expression of inflammatory markers tumor necrosis factor-α, IL-6 receptor and the E3 ligase MuRF-1 involved in muscle proteolysis. In epididymal adipose tissue, tumor-driven delipidation and atrophy was aggravated by the c9,t11-CLA-rich oil, demonstrated by further reduced adipocyte size and lower adiponectin expression. However, expression of inflammatory cytokines and macrophage markers were not altered by tumors, or CLA supplementation. These data suggest that addition of c9t11-CLA-rich oil (0.6% c9t11, 0.1% t10c12) in diet did not ameliorate wasting in mice with cancer cachexia. Instead, it increased expression of inflammatory markers in the muscle and increased adipose delipidation.